Cargando…

The comparison of MRN, electrophysiology and progression among typical CIDP and atypical CIDP subtypes

We aimed to compare the electrophysiology and magnetic resonance neurography (MRN) results of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) subtypes and to explore the progression from atypical CIDP to typical CIDP. We collected the medical records of 45 CIDP patients to analyse t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Yuan, Zhang, Yu, Su, Xiaoyun, Zheng, Chuansheng, Lu, Zuneng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541655/ https://www.ncbi.nlm.nih.gov/pubmed/33028841 http://dx.doi.org/10.1038/s41598-020-73104-1

Ejemplares similares

The Noninvasive Diagnostic Value of MRN for CIDP: A Research from Qualitative to Quantitative
por: Feng, Yuan, et al.
Publicado: (2020)

Treatment Approaches for Atypical CIDP
por: Menon, Deepak, et al.
Publicado: (2021)

Progress in Hematopoietic Stem Cell Transplantation for CIDP
por: Qin, Zhen, et al.
Publicado: (2020)

The Misdiagnosis of CIDP: A Review
por: Allen, Jeffrey A.
Publicado: (2020)

Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDP
por: Staudt, M., et al.
Publicado: (2017)

Severe CIDP-MGUS responsive to Rituximab
por: Posa, Andreas, et al.
Publicado: (2020)

CIDP mimics: a case series
por: Moshe-Lilie, Orly, et al.
Publicado: (2021)

MRI biomarkers of proximal nerve injury in CIDP
por: Lichtenstein, Thorsten, et al.
Publicado: (2017)

Editorial: Update on the Diagnosis and Management of CIDP Variants
por: Chroni, Elisabeth, et al.
Publicado: (2021)

The neurophysiological lesson from the Italian CIDP database
por: Spina, Emanuele, et al.
Publicado: (2021)

CIDP/autoimmune nodopathies with nephropathy: a case series study
por: Tang, Yuwei, et al.
Publicado: (2023)

Deregulated Fcγ receptor expression in patients with CIDP
por: Quast, Isaak, et al.
Publicado: (2015)

CIDP prognosis in patients with IVIG treatment‐related fluctuations
por: Cook, Melissa, et al.
Publicado: (2022)

Comparison of diabetes patients with “demyelinating” diabetic sensorimotor polyneuropathy to those diagnosed with CIDP
por: Dunnigan, Samantha K, et al.
Publicado: (2013)

Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins
por: Querol, Luis, et al.
Publicado: (2015)

Terminal complement activation is increased and associated with disease severity in CIDP
por: Quast, Isaak, et al.
Publicado: (2016)

Nerve pathologic features differentiate POEMS syndrome from CIDP
por: Piccione, Ezequiel A., et al.
Publicado: (2016)

NK cell markers predict the efficacy of IV immunoglobulins in CIDP
por: Mausberg, Anne K., et al.
Publicado: (2020)

Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP
por: Querol, Luis, et al.
Publicado: (2021)

Pediatric CIDP: Diagnosis and Management. A Single-Center Experience
por: Łukawska, Małgorzata, et al.
Publicado: (2021)

Serum Contactin-1 in CIDP: A Cross-Sectional Study
por: Wieske, Luuk, et al.
Publicado: (2021)

A Case of Relapsing - Remitting CIDP with Sixth Nerve Palsy
por: Thelengana, Arikrishnan, et al.
Publicado: (2021)

Two CIDP Variants Patients With Anti-Caspr1 Antibodies in South China
por: Li, Chong, et al.
Publicado: (2022)

Treatment Responsiveness in CIDP Patients with Diabetes Is Associated with Higher Degrees of Demyelination
por: Abraham, Alon, et al.
Publicado: (2015)

Loss of Schwann cell plasticity in chronic inflammatory demyelinating polyneuropathy (CIDP)
por: Joshi, Abhijeet R., et al.
Publicado: (2016)

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies
por: Merkies, Ingemar S.J., et al.
Publicado: (2019)

The economic burden of CIDP in the United States: A case-control study
por: Divino, Victoria, et al.
Publicado: (2018)

Retrospective correlation analysis of plasma Immunoglobulin G and clinical performance in CIDP
por: Markvardsen, Lars Kjøbsted, et al.
Publicado: (2019)

Abnormality of multimodal evoked potentials in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
por: Dziadkowiak, Edyta, et al.
Publicado: (2020)

The Cost Effectiveness of Immunoglobulin vs. Hematopoietic Stem Cell Transplantation for CIDP
por: Burt, Richard K., et al.
Publicado: (2021)

Corrigendum: Pediatric CIDP: Diagnosis and Management. A Single-Center Experience
por: Łukawska, Małgorzata, et al.
Publicado: (2022)

Pathophysiology of the Different Clinical Phenotypes of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
por: Dziadkowiak, Edyta, et al.
Publicado: (2021)

Evaluation of the EFNS/PNS diagnostic criteria in a cohort of CIDP patients
por: Athanasopoulos, Diamantis, et al.
Publicado: (2021)

Neurophysiological Hallmarks of Axonal Degeneration in CIDP Patients: A Pilot Analysis
por: Ricciardi, Dario, et al.
Publicado: (2022)

CIDP: a multi-functional platform for designing CRISPR sgRNAs
por: Xu, Dong, et al.
Publicado: (2023)

Deterioration after corticosteroids in CIDP may be associated with pure focal demyelination pattern
por: Eftimov, Filip, et al.
Publicado: (2014)

CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS
por: Capodivento, Giovanna, et al.
Publicado: (2021)

Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP)
por: Querol, Luis, et al.
Publicado: (2020)

Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDP
por: Breville, Gautier, et al.
Publicado: (2021)

CIDP Antibodies Target Junction Proteins and Identify Patient Subgroups: An Autoantigenomic Approach
por: Moritz, Christian P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gsvk1dbq07kbegg9gtobdovutq